MedTrace Logo

Safety and Efficacy of Honeycomb Microporous Covered Stents (NCVC-CS1) for the Treatment of Intracranial Aneurysms

NCT02907229 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2019-03-13

No results posted yet for this study

Summary

This trial is conducted to evaluate the safety and technical effectiveness of using NCVC-CS1, a newly developed honeycomb microporous covered stent, for the treatment of intracranial aneurysms which are difficult to be cured by conventional surgical or endovascular procedures.

Conditions

  • Intracranial Aneurysm

Interventions

DEVICE

NCVC-CS1

Intervention Description

Sponsors & Collaborators

  • Kobe City General Hospital

    collaborator OTHER

  • Juntendo University

    collaborator OTHER

  • Kyoto University

    collaborator OTHER

  • National Cerebral and Cardiovascular Center, Japan

    lead OTHER

Principal Investigators

  • Tetsu Satow · National Cerebral and Cardiovascular Center, Japan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-01-25
Completion
2019-03-04

Countries

  • Japan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02907229 on ClinicalTrials.gov